Clover Health to Participate in Upcoming Investor Conferences
Rhea-AI Summary
Clover Health (Nasdaq: CLOV) has announced its participation in two major upcoming investor conferences in May 2025. Chief Financial Officer Peter Kuipers will lead the company's presence at these events:
- A presentation at the 2025 Bank of America Healthcare Conference on May 14, 2025, at 6:00 p.m. Eastern Time, which will be available via live webcast and replay on Clover's investor relations website
- Participation in the 22nd Annual Craig-Hallum Institutional Investor Conference on May 28, 2025
Positive
- None.
Negative
- None.
News Market Reaction – CLOV
In the trading session that priced this news, CLOV gained 1.81%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WILMINGTON, Del., April 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced its participation in the following investor conferences:
- CFO, Peter Kuipers, will present at the 2025 Bank of America Healthcare Conference on Wednesday, May 14, 2025, at 6:00 p.m. Eastern Time. A live webcast and replay of the presentation will be accessible from Clover Health's investor relations website at https://investors.cloverhealth.com/.
- CFO, Peter Kuipers, will participate in the 22nd Annual Craig-Hallum Institutional Investor Conference on Wednesday, May 28, 2025.
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
Investor Relations:
Ryan Schmidt
investors@cloverhealth.com
Press Inquiries:
press@cloverhealth.com
